Hetero and Glenmark Launch Adalimumab Biosimilars in India

Published date08 January 2018
Law FirmGoodwin
Subject MatterPrescription Drugs,Biosimilars,India,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT